Candel Therapeutics, Inc. Profile Avatar - Palmy Investing

Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase I…

Biotechnology
US, Needham [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Candel Therapeutics, Inc. (CADL) to it's peer group.

Peer Group
AVTE MNPR RZLT ENOB PMVP TPST MLYS PEPG INDP ANEB FBRX ACXP ACRV CMRA ANTX Compare Together
Loading...
End of CADL's Analysis
CIK: 1841387 CUSIP: 137404109 ISIN: US1374041093 LEI: - UEI: -
Secondary Listings
CADL has no secondary listings inside our databases.